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in more number of patients in study group ( p = .003). From one
month to sixmonth signiﬁcantlymore number of patients in study
group hadMI and repeat revascularization. Total number of death,
myocardial infarction and repeat revascularization at one yearwas
signiﬁcantly more in study group as compared to control group.
Statistically higher number of patients in study group had com-
bined MACCE at one year as compared to control group (<.001).
Conclusions: During and after PCI decreased creatinine clearance
is independently associated with death and major adverse events.
It is a powerful predictor of in-hospital myocardial infarction and
1-year ischemic events including death, MI and repeat revascular-
ization renal dysfunction patients.
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Background: Coronary artery disease (CAD) continues to be the
main cause of death worldwide. Data available from clinical trials
or registries does not adequately represent populations with stable
CAD. It is important to have longitudinal observations of a repre-
sentative large cohort of patients with stable CAD, spanning sev-
eral geographic regions, focusing on stable outpatients (as opposed
to patients hospitalized or recently discharged from hospitals for
acute manifestations of the disease), and including both sympto-
matic and asymptomatic patients.
Method: CLARIFY (The prospeCtive observational LongitudinAl
RegIstry oF patients with stable coronary arterY disease) is an
international, prospective, observational, longitudinal registry of
outpatientswith stable CAD, deﬁned as priormyocardial infarction
or revascularization procedure, evidence of coronary stenosis of
>50%, or chest pain associated with proven myocardial ischemia.
A total of 33,438 patients were enrolled from 45 countries in Africa,
Asia, Australia, Europe, the Middle East, and North, Central and
South America. 809 patients were recruited from India, with repre-
sentation from various cities. The data was collected at baseline
and annually for 5 years to ascertain clinical events, hospitaliza-
tion etc.
Results: Indian population differed from the global population in
terms of having more patients with history of diabetes (44.3% vs.
28.73%) and average heart rate (76.6 bpm vs. 68.3 bpm) at baseline.
The 2 years outcomes data is in table
Outcome Level n with event/n
ill group (%)
HR (95% CI) p-Value
All cause death 1: Total CLARIFY population (excluding India) 952/31,693 (3.0%) 1.00 (–) 0.3930
2: India 28/805 (3.5%) 1.18 (0.81. 1.72)
Cardiovascular death 1: Total CLARIFY population (excluding India) 458/31,692 (1.4%) 1.00 (–) 0.8715
2: India 12/805 (1.5%) 1.05 (0.59. 1.86)
Non-cardiovascular death 1: Total CLARIFY population (excluding India) 308/31,692 (1.0%) 1.00 (–) 0.4048
2: India 10/805 (1.2%) 1.31 (0.7, 2.45)
Unknown cause of death 1: Total CLARIFY population (excluding India) 186/31,693 (0.6%) 1.00 (–) 0.5404
2: India 6/805 (0.7%) 1.29 (0.57. 2.91)
Myocardial infarction
(fatal or non-fatal)
1: Total CLARIFY population (excluding India) 543/31,689 (1.7%) 1.00 (–) 0.0256
2: India 5/805 (0.6%) 0.37 (0.15,0.88)
Stroke (fatal or non-fatal) 1: Total CLARIFY population (excluding India) 296/31,689 (0.9%) 1.00 (–) 0.8738
2: India 7/805 (0.9%) 0.94(0.45. 1.99)
Cardiovascular death or non-fatal MI 1: Total CLARIFY population (excluding India) 830/31,689 (2.6%) 1.00 (–) 0.0903
2: India 13/805 (1.6%) 0.62 (0.36. 1.08)
Cardiovascular death.
Non-fatal MI or non-fatal stroke
1: Total CLARIFY population (excluding India) 1049/31,689 (3.3%) 1.00 (–) 0.0458
2: India 16/805 (2.0%) 0.6 (0.37. 0.99)
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